Download Your Copy of the 2025 Agenda
The Antifibrotic Drug Development Summit stands as the premier industry-driven forum bringing together drug developers across IPF, MASH, systemic sclerosis, and kidney, cardiac, and gastrointestinal fibrosis to address common challenges from early discovery through Phase 2.
Download the agenda to explore last years sessions, including deep-dive workshops on chronic fibrosis modeling, clinical case studies, and panels debating post-GLP-1 positioning.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.